Verrica Pharmaceuticals Investor Relations Material
Latest events
Q1 2025
Verrica Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Verrica Pharmaceuticals Inc
Access all reports
Verrica Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for dermatological conditions, particularly those requiring medical interventions. The company is dedicated to addressing the unmet needs in medical dermatology by identifying, developing, and commercializing novel pharmaceutical products. Its pipeline includes product candidates aimed at treating a variety of skin diseases, leveraging research to offer new therapeutic options to patients and healthcare providers. The company is headquartered in West Chester, Pennsylvania, and its shares are listed on the Nasdaq.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
VRCA
Country
🇺🇸 United States